Cargando…
Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells
We have used a computational approach to identify anti-fibrotic therapies by querying a transcriptome. A transcriptome signature of activated hepatic stellate cells (HSCs), the primary collagen-secreting cell in liver, and queried against a transcriptomic database that quantifies changes in gene exp...
Autores principales: | Hicks, Daniel F., Goossens, Nicolas, Blas-García, Ana, Tsuchida, Takuma, Wooden, Benjamin, Wallace, Michael C., Nieto, Natalia, Lade, Abigale, Redhead, Benjamin, Cederbaum, Arthur I, Dudley, Joel T., Fuchs, Bryan C., Lee, Youngmin A., Hoshida, Yujin, Friedman, Scott L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335661/ https://www.ncbi.nlm.nih.gov/pubmed/28256512 http://dx.doi.org/10.1038/srep42563 |
Ejemplares similares
-
β-PDGF Receptor Expressed by Hepatic Stellate Cells Regulates Fibrosis in Murine Liver Injury, but Not Carcinogenesis
por: Kocabayoglu, Peri, et al.
Publicado: (2015) -
The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy
por: Kim, Rosa S., et al.
Publicado: (2016) -
Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseases
por: Bansal, Ruchi, et al.
Publicado: (2017) -
Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
por: Lin, Zesi, et al.
Publicado: (2015) -
Fibrotic expression profile analysis reveals repurposed drugs with potential anti-fibrotic mode of action
por: Karatzas, Evangelos, et al.
Publicado: (2021)